[1]
|
Joaquin, M. and Watson, R.J. (2003) Cell Cycle Regulation by the B-Myb Transcription Factor. Cellular and Molecular Life Sciences, 60, 2389-2401. https://doi.org/10.1007/s00018-003-3037-4
|
[2]
|
Pascale, R.M., Calvisi, D.F., Feo, F. and Simile, M.M. (2022) Genetic Predisposition to Hepatocellular Carcinoma. Metabolites, 13, Article 35. https://doi.org/10.3390/metabo13010035
|
[3]
|
Xiong, Y.C., Wang, J., Cheng, Y., Zhang, X.Y. and Ye, X.Q. (2020) Overexpression of MYBL2 Promotes Proliferation and Migration of Non-Small-Cell Lung Cancer via Upregulating NCAPH. Molecular and Cellular Biochemistry, 468, 185-193. https://doi.org/10.1007/s11010-020-03721-x
|
[4]
|
Yuan, J., Zhang, Y., Sheng, Y., et al. (2015) MYBL2 Guides Autophagy Suppressor VDAC2 in the Developing Ovary to Inhibit Autophagy through a Complex of VDAC2-BECN1-BCL2L1 in Mammals. Autophagy, 11, 1081-1098. https://doi.org/10.1080/15548627.2015.1040970
|
[5]
|
Greene, L.A., Liu, D.X., Troy, C.M., et al. (2007) Cell Cycle Molecules Define a Pathway Required for Neuron Death in Development and Disease. Biochimica et Biophysicaacta, 1772, 392-401. https://doi.org/10.1016/j.bbadis.2006.12.003
|
[6]
|
Liu, D.X., Biswas, S.C. and Greene, L.A. (2004) B-Myb and C-Myb Play Required Roles in Neuronal Apoptosis Evoked by Nerve Growth Factor Deprivation and DNA Damage. Journal of Neuroscience, 24, 8720-8725. https://doi.org/10.1523/JNEUROSCI.1821-04.2004
|
[7]
|
Huang, Y., Wu, J., Li, R., et al. (2011) B-Myb Delays Cell Aging by Repressing p16 INK4α Transcription. Cellular and Molecular Life Sciences, 68, 893-901. https://doi.org/10.1007/s00018-010-0501-9
|
[8]
|
Diepenbruck, M. and Christofori, G. (2016) Epithelial-Mesenchymal Transition (EMT) and Metastasis: Yes, No, Maybe? Current Opinion in Cell Biology, 43, 7-13. https://doi.org/10.1016/j.ceb.2016.06.002
|
[9]
|
Tao, D., Pan, Y., Jiang, G., et al. (2015) B-Myb Regulates Snail Expression to Promote Epithelial-to-Mesenchymal Transition and Invasion of Breast Cancer Cell. Medical Oncology, 32, Article No. 412. https://doi.org/10.1007/s12032-014-0412-y
|
[10]
|
Xin, Z., Li, Y., Meng, L., Dong, L., Ren, J. and Men, J. (2022) Elevated Expression of the MYB Proto-Oncogene Like 2 (MYBL2)-Encoding Gene as a Prognostic and Predictive Biomarker in Human Cancers. Mathematical Biosciences and Engineering, 19, 1825-1842.
|
[11]
|
Musa, J., Aynaud, M., Mirabeau, O., et al. (2017) MYBL2 (B-Myb): A Central Regulator of Cell Proliferation, Cell Survival and Differentiation Involved in Tumorigenesis. Cell Death & Disease, 8, e2895. https://doi.org/10.1038/cddis.2017.244
|
[12]
|
Heinrichs, S., Conover, L.F., Bueso-Ramos, C.E., et al. (2013) MYBL2 Is a Sub-Haploinsufficient Tumor Suppressor Gene in Myeloid Malignancy. elife, 2, e825. https://doi.org/10.7554/eLife.00825
|
[13]
|
杨明, 朱旭东, 沈炀, 等. MYBL2在前列腺癌患者组织中高表达并与不良预后相关[J]. 南方医科大学学报, 2022, 42(8): 1109-1118.
|
[14]
|
Yoshikawa, Y., Stopsack, K.H., Wang, X.V., et al. (2022) Increased MYBL2 Expression in Aggressive Hormone-Sensitive Prostate Cancer. Molecular Oncology, 16, 3994-4010. https://doi.org/10.1002/1878-0261.13314
|
[15]
|
马冰冰. 膀胱癌组织中MYBL2、AGR2、PAX8及NR4A3表达与临床病理特征及预后的相关性[J]. 实用癌症杂志, 2024, 39(2): 219-221.
|
[16]
|
Liu, W., Shen, D., Ju, L., et al. (2022) MYBL2 Promotes Proliferation and Metastasis of Bladder Cancer through Transactivation of CDCA3. Oncogene, 41, 4606-4617. https://doi.org/10.1038/s41388-022-02456-x
|
[17]
|
Zhong, F., Liu, J., Gao, C., Chen, T. and Li, B. (2022) Downstream Regulatory Network of MYBL2 Mediating Its Oncogenic Role in Melanoma. Frontiers in Oncology, 12, Article 816070. https://doi.org/10.3389/fonc.2022.816070
|
[18]
|
Deng, Q., Wu, L., Li, Y. and Zou, L. (2021) MYBL2 in Synergy with CDC20 Promotes the Proliferation and Inhibits Apoptosis of Gastric Cancer Cells. Advances in Clinical and Experimental Medicine, 30, 957-966. https://doi.org/10.17219/acem/135938
|
[19]
|
Uvale, K., Shaik, A. and Kirubakaran, S. (2019) Inhibitors of Inosine 5’-Monophosphate Dehydrogenase as Emerging New Generation Antimicrobial Agents. MedChemComm, 10, 1290-1301. https://doi.org/10.1039/C9MD00179D
|
[20]
|
Zhao, J.Z., Wang, W., Liu, T., et al. (2022) MYBL2 Regulates Denovo Purine Synthesis by Transcriptionally Activating IMPDH1 in Hepatocellular Carcinoma Cells. BMC Cancer, 22, Article No. 1290. https://doi.org/10.1186/s12885-022-10354-4
|
[21]
|
Wei, M., Yang, R., Ye, M., et al. (2022) MYBL2 Accelerates Epithelial-Mesenchymal Transition and Hepatoblastoma Metastasis via the Smad/SNAI1 Pathway. American Journal of Cancer Research, 12, 1960-1981.
|
[22]
|
Bayley, R., Ward, C. and Garcia, P. (2020) MYBL2 Amplification in Breast Cancer: Molecular Mechanisms and Therapeutic Potential. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1874, Article 188407. https://doi.org/10.1016/j.bbcan.2020.188407
|
[23]
|
Thorner, A.R., Hoadley, K.A., Parker, J.S., et al. (2009) In Vitro and in Vivo Analysis of B-Myb in Basal-Like Breast Cancer. Oncogene, 28, 742-751. https://doi.org/10.1038/onc.2008.430
|
[24]
|
许林波, 梁丽斯, 王蓓, 等. 血浆M-CSF、MMP9、TIMP-1水平及HPV阳性大鼠宫颈癌增殖能力的关系研究[J]. 现代生物医学进展, 2022, 22(8): 1439-1443.
|
[25]
|
林金端, 刘红伟, 张欣宁, 等. Mybl2在不同病变程度宫颈组织中的表达[J]. 现代检验医学杂志, 2017, 32(2): 141-142, 145.
|
[26]
|
林金端, 刘红伟, 李介华, 等. 宫颈上皮脱落细胞mybl2 mRNA表达水平及意义[J]. 广东医学, 2017, 38(18): 2814-2816.
|
[27]
|
Chen, T., Yang, S., Xu, J., Lu, W. and Xie, X. (2020) Transcriptome Sequencing Profiles of Cervical Cancer Tissues and SiHa Cells. Functional & Integrative Genomics, 20, 211-221. https://doi.org/10.1007/s10142-019-00706-y
|
[28]
|
Qiu, H.Z., Huang, J., Xiang, C.C., et al. (2020) Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis. Technology in Cancer Research & Treatment, 19, Article 1533033820980112. https://doi.org/10.1177/1533033820980112
|
[29]
|
Chiarini, A., Liu, D., Rassu, M., Armato, U., Eccher, C. and Dal Prà, I. (2019) Over Expressed TKTL1, CIP-2A, and B-Myb Proteins in Uterine Cervix Epithelium Scrapings as Potential Risk Predictive Biomarkers in HR-HPV-Infected LSIL/ASCUS Patients. Frontiers in Oncology, 9, Article 213. https://doi.org/10.3389/fonc.2019.00213
|
[30]
|
Le, L., Luo, J., Wu, H., Chen, L., Tang, X. and Fu, F. (2021) Overexpression of MYBL2 Predicts Poor Prognosis and Promotes Oncogenesis in Endometrial Carcinoma. European Journal of Histochemistry, 65, Article 3226. https://doi.org/10.4081/ejh.2021.3226
|
[31]
|
乐露露. 子宫内膜癌关键基因的筛选及分子机制研究[D]: [博士学位论文]. 南昌: 南昌大学, 2022.
|
[32]
|
Häring, J., Skrzypczak, M., Stegerer, A., et al. (2012) Estrogen Receptor β Transcript Variants Associate with Oncogene Expression in Endometrial Cancer. International Journal of Molecular Medicine, 29, 1127-1136.
|
[33]
|
Liu, Q., Yu, M. and Zhang, T. (2022) Construction of Oxidative Stress-Related Genes Risk Model Predicts the Prognosis of Uterine Corpus Endometrial Cancer Patients. Cancers, 14, Article 5572. https://doi.org/10.3390/cancers14225572
|
[34]
|
许丁文, 雒森, 袁红网, 等. 基于生物信息学分析MYBL2在卵巢癌耐药性中的作用及其机制[J]. 中国现代应用药学, 2020, 37(10): 1166-1170.
|
[35]
|
Iness, A.N., Felthousen, J., Ananthapadmanabhan, V., et al. (2019) The Cell Cycle Regulatory DREAM Complex Is Disrupted by High Expression of Oncogenic B-Myb. Oncogene, 38, 1080-1092. https://doi.org/10.1038/s41388-018-0490-y
|
[36]
|
Iness, A.N., Rubinsak, L., Meas, S.J., et al. (2021) Oncogenic B-Myb Is Associated with Deregulation of the DREAM-Mediated Cell Cycle Gene Expression Program in High Grade Serous Ovarian Carcinoma Clinical Tumor Samples. Frontiers in Oncology, 11, Article 637193. https://doi.org/10.3389/fonc.2021.637193
|
[37]
|
Liu, Q., Liu, H., Huang, X., et al. (2023) A Targetable MYBL2-ATAD2 Axis Governs Cell Proliferation in Ovarian Cancer. Cancer Gene Therapy, 30, 192-208. https://doi.org/10.1038/s41417-022-00538-2
|
[38]
|
Qi, G., Zhang, C., Ma, H., et al. (2021) CDCA8, Targeted by MYBL2, Promotes Malignant Progression and Olaparib Insensitivity in Ovarian Cancer. American Journal of Cancer Research, 11, 389-415.
|
[39]
|
Han, J., Xie, R., Yang, Y., et al. (2021) CENPA Is One of the Potential Key Genes Associated with the Proliferation and Prognosis of Ovarian Cancer Based on Integrated Bioinformatics Analysis and Regulated by MYBL2. Translational Cancer Research, 10, 4076-4086. https://doi.org/10.21037/tcr-21-175
|
[40]
|
Pan, B., Wan, T., Zhou, Y., et al. (2023) The MYBL2-CCL2 Axis Promotes Tumor Progression and Resistance to Anti-PD-1 Therapy in Ovarian Cancer by Inducing Immunosuppressive Macrophages. Cancer Cell International, 23, Article No. 248. https://doi.org/10.1186/s12935-023-03079-2
|